NL106036C - - Google Patents
Info
- Publication number
- NL106036C NL106036C NL240357A NL240357A NL106036C NL 106036 C NL106036 C NL 106036C NL 240357 A NL240357 A NL 240357A NL 240357 A NL240357 A NL 240357A NL 106036 C NL106036 C NL 106036C
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US743492A US2894963A (en) | 1958-06-20 | 1958-06-20 | 9,11-dihalogeno-4-pregnenes and 1,4-pregnadienes |
| CA775651 | 1959-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL106036C true NL106036C (fr) | 1963-09-16 |
Family
ID=25673299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL240357A NL106036C (fr) | 1958-06-20 | 1959-06-18 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE579900A (fr) |
| CH (1) | CH386415A (fr) |
| DK (1) | DK118874B (fr) |
| ES (1) | ES250249A1 (fr) |
| FR (1) | FR564M (fr) |
| GB (2) | GB928301A (fr) |
| NL (1) | NL106036C (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3397213A (en) * | 1966-01-12 | 1968-08-13 | Squibb & Sons Inc | 12 methyl-9, 11-dihaloprogesterones |
| FR2342738A1 (fr) * | 1976-03-02 | 1977-09-30 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
| ES2744879T3 (es) | 2008-05-28 | 2020-02-26 | Reveragen Biopharma Inc | Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades |
| WO2011127048A2 (fr) | 2010-04-05 | 2011-10-13 | Validus Biopharma | MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
1959
- 1959-06-11 GB GB20033/59A patent/GB928301A/en not_active Expired
- 1959-06-11 GB GB43100/61A patent/GB928302A/en not_active Expired
- 1959-06-18 NL NL240357A patent/NL106036C/xx active
- 1959-06-18 CH CH7465759A patent/CH386415A/fr unknown
- 1959-06-19 ES ES0250249A patent/ES250249A1/es not_active Expired
- 1959-06-19 DK DK220659AA patent/DK118874B/da unknown
- 1959-06-20 BE BE579900A patent/BE579900A/fr unknown
-
1960
- 1960-08-30 FR FR837195A patent/FR564M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BE579900A (fr) | 1959-10-16 |
| CH386415A (fr) | 1965-01-15 |
| DK118874B (da) | 1970-10-19 |
| GB928301A (en) | 1963-06-12 |
| FR564M (fr) | 1961-06-05 |
| GB928302A (en) | 1963-06-12 |
| ES250249A1 (es) | 1960-01-16 |